Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Rowin EJ"" wg kryterium: Autor


Tytuł :
Is Regression of Left Ventricular Hypertrophy Really a Good Thing for Patients With Hypertrophic Cardiomyopathy?: The Emerging Mavacamten Story.
Autorzy :
Maron BJ; HCM Institute, Tufts Medical Center, Boston, Massachusetts. Electronic address: .
Rowin EJ; HCM Institute, Tufts Medical Center, Boston, Massachusetts.
Maron MS; HCM Institute, Tufts Medical Center, Boston, Massachusetts.
Pokaż więcej
Źródło :
The American journal of cardiology [Am J Cardiol] 2021 May 15; Vol. 147, pp. 145-146. Date of Electronic Publication: 2021 Feb 04.
Typ publikacji :
Editorial
Opinia redakcyjna
Tytuł :
Evaluating Histopathology to Improve Our Understanding of Hypertrophic Cardiomyopathy.
Autorzy :
Rowin EJ; Hypertrophic Cardiomyopathy Center, Division of Cardiology, CardioVascular Center, Tufts Medical Center, Boston, Massachusetts, USA. Electronic address: .
Fifer MA; Hypertrophic Cardiomyopathy Program, Cardiology Division, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Pokaż więcej
Źródło :
Journal of the American College of Cardiology [J Am Coll Cardiol] 2021 May 04; Vol. 77 (17), pp. 2171-2173.
Typ publikacji :
Editorial
Opinia redakcyjna
Tytuł :
Progression of Myocardial Fibrosis in Hypertrophic Cardiomyopathy: A Cardiac Magnetic Resonance Study.
Autorzy :
Habib M; Peter Munk Cardiac Centre, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada.
Adler A; Peter Munk Cardiac Centre, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada.
Fardfini K; Peter Munk Cardiac Centre, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada.
Hoss S; Peter Munk Cardiac Centre, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada.
Hanneman K; Peter Munk Cardiac Centre, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada.
Rowin EJ; Division of Cardiology, Hypertrophic Cardiomyopathy Institute, Tufts Medical Center, Boston, Massachusetts.
Maron MS; Division of Cardiology, Hypertrophic Cardiomyopathy Institute, Tufts Medical Center, Boston, Massachusetts.
Maron BJ; Division of Cardiology, Hypertrophic Cardiomyopathy Institute, Tufts Medical Center, Boston, Massachusetts.
Rakowski H; Peter Munk Cardiac Centre, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada.
Chan RH; Peter Munk Cardiac Centre, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada. Electronic address: .
Pokaż więcej
Źródło :
JACC. Cardiovascular imaging [JACC Cardiovasc Imaging] 2021 May; Vol. 14 (5), pp. 947-958. Date of Electronic Publication: 2020 Nov 25.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Plasma Proteomic Profiling in Hypertrophic Cardiomyopathy Patients before and after Surgical Myectomy Reveals Post-Procedural Reduction in Systemic Inflammation.
Autorzy :
Larson A; Molecular Cardiology Research Institute, Tufts Medical Center, Boston, MA 02111, USA.
Libermann TA; Genomics, Proteomics, Bioinformatics and Systems Biology Center, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02115, USA.
Bowditch H; Molecular Cardiology Research Institute, Tufts Medical Center, Boston, MA 02111, USA.
Das G; Molecular Cardiology Research Institute, Tufts Medical Center, Boston, MA 02111, USA.
Diakos N; CardioVascular Center, Tufts Medical Center, Boston, MA 02111, USA.
Huggins GS; Molecular Cardiology Research Institute, Tufts Medical Center, Boston, MA 02111, USA.; CardioVascular Center, Tufts Medical Center, Boston, MA 02111, USA.
Rastegar H; CardioVascular Center, Tufts Medical Center, Boston, MA 02111, USA.; Hypertrophic Cardiomyopathy Center, Tufts Medical Center, Boston, MA 02111, USA.
Chen FY; CardioVascular Center, Tufts Medical Center, Boston, MA 02111, USA.
Rowin EJ; CardioVascular Center, Tufts Medical Center, Boston, MA 02111, USA.; Hypertrophic Cardiomyopathy Center, Tufts Medical Center, Boston, MA 02111, USA.
Maron MS; CardioVascular Center, Tufts Medical Center, Boston, MA 02111, USA.; Hypertrophic Cardiomyopathy Center, Tufts Medical Center, Boston, MA 02111, USA.
Chin MT; Molecular Cardiology Research Institute, Tufts Medical Center, Boston, MA 02111, USA.; CardioVascular Center, Tufts Medical Center, Boston, MA 02111, USA.; Hypertrophic Cardiomyopathy Center, Tufts Medical Center, Boston, MA 02111, USA.
Pokaż więcej
Źródło :
International journal of molecular sciences [Int J Mol Sci] 2021 Mar 01; Vol. 22 (5). Date of Electronic Publication: 2021 Mar 01.
Typ publikacji :
Journal Article
MeSH Terms :
Biomarkers/*blood
Cardiac Surgical Procedures/*methods
Cardiomyopathy, Hypertrophic/*surgery
Inflammation/*prevention & control
Proteome/*analysis
Adult ; Aged ; Cardiomyopathy, Hypertrophic/metabolism ; Cardiomyopathy, Hypertrophic/pathology ; Female ; Humans ; Inflammation/blood ; Male ; Middle Aged
Czasopismo naukowe
Tytuł :
After 60 Years Hypertrophic Cardiomyopathy is Finally Recognized as a Contemporary Treatable Disease With Low Mortality and Morbidity, But is This Paradigm Under-Recognized in the Literature?
Autorzy :
Maron BJ; Tufts Medical Center, Boston, Massachusetts. Electronic address: .
Rowin EJ; Tufts Medical Center, Boston, Massachusetts.
Maron MS; Tufts Medical Center, Boston, Massachusetts.
Pokaż więcej
Źródło :
The American journal of cardiology [Am J Cardiol] 2021 Mar 01; Vol. 142, pp. 136-137. Date of Electronic Publication: 2020 Dec 10.
Typ publikacji :
Editorial
MeSH Terms :
Cardiomyopathy, Hypertrophic/*therapy
Cardiac Surgical Procedures ; Cardiomyopathy, Hypertrophic/mortality ; Cardiomyopathy, Hypertrophic/physiopathology ; Death, Sudden, Cardiac/prevention & control ; Defibrillators, Implantable ; Disease Management ; Heart Failure/drug therapy ; Heart Failure/physiopathology ; Humans ; Morbidity ; Publication Bias ; Risk Assessment
Opinia redakcyjna
Tytuł :
Low Risk of Hypertrophic Cardiomyopathy With Contemporary Management Strategies Implemented in Non-Referral Regional Community-Based Practices.
Autorzy :
Shirani J; Hypertrophic Cardiomyopathy Clinic and Heart and Vascular Center, St. Luke's University Health Network, Bethlehem, Pennsylvania; Hypertrophic Cardiomyopathy Institute, Tufts Medical Center, Boston, Massachusetts. Electronic address: .
Aurshiya R; Hypertrophic Cardiomyopathy Clinic and Heart and Vascular Center, St. Luke's University Health Network, Bethlehem, Pennsylvania; Hypertrophic Cardiomyopathy Institute, Tufts Medical Center, Boston, Massachusetts.
Elshaikh A; Hypertrophic Cardiomyopathy Clinic and Heart and Vascular Center, St. Luke's University Health Network, Bethlehem, Pennsylvania; Hypertrophic Cardiomyopathy Institute, Tufts Medical Center, Boston, Massachusetts.
Olenchock SA; Hypertrophic Cardiomyopathy Clinic and Heart and Vascular Center, St. Luke's University Health Network, Bethlehem, Pennsylvania; Hypertrophic Cardiomyopathy Institute, Tufts Medical Center, Boston, Massachusetts.
Rowin EJ; Hypertrophic Cardiomyopathy Clinic and Heart and Vascular Center, St. Luke's University Health Network, Bethlehem, Pennsylvania; Hypertrophic Cardiomyopathy Institute, Tufts Medical Center, Boston, Massachusetts.
Maron MS; Hypertrophic Cardiomyopathy Clinic and Heart and Vascular Center, St. Luke's University Health Network, Bethlehem, Pennsylvania; Hypertrophic Cardiomyopathy Institute, Tufts Medical Center, Boston, Massachusetts.
Maron BJ; Hypertrophic Cardiomyopathy Clinic and Heart and Vascular Center, St. Luke's University Health Network, Bethlehem, Pennsylvania; Hypertrophic Cardiomyopathy Institute, Tufts Medical Center, Boston, Massachusetts.
Pokaż więcej
Źródło :
The American journal of cardiology [Am J Cardiol] 2021 Mar 01; Vol. 142, pp. 130-135. Date of Electronic Publication: 2020 Dec 03.
Typ publikacji :
Journal Article
MeSH Terms :
Defibrillators, Implantable*
Ablation Techniques/*methods
Cardiomyopathy, Hypertrophic/*therapy
Death, Sudden, Cardiac/*prevention & control
Ventricular Septum/*surgery
Adult ; Aged ; Aged, 80 and over ; Cardiac Surgical Procedures/methods ; Cardiomyopathy, Hypertrophic/diagnostic imaging ; Cardiomyopathy, Hypertrophic/mortality ; Cardiomyopathy, Hypertrophic/physiopathology ; Cohort Studies ; Community Health Services ; Disease Management ; Electric Countershock/statistics & numerical data ; Female ; Heart Failure/diagnostic imaging ; Heart Failure/physiopathology ; Humans ; Male ; Middle Aged ; Multi-Institutional Systems ; Tertiary Care Centers ; Ventricular Outflow Obstruction/diagnostic imaging ; Ventricular Outflow Obstruction/physiopathology
Czasopismo naukowe
Tytuł :
Erratum to "Hypertrophic Cardiomyopathy: Is a 'Cure' Coming … Or Is It Already Here?": American Journal of Medicine, 133 (2020):8:886-888.
Autorzy :
Maron BJ; Hypertrophic Cardiomyopathy Institute, Division of Cardiology, Tufts Medical Center, Boston MA.
Rowin EJ; Hypertrophic Cardiomyopathy Institute, Division of Cardiology, Tufts Medical Center, Boston MA.
Maron MS; Hypertrophic Cardiomyopathy Institute, Division of Cardiology, Tufts Medical Center, Boston MA.
Pokaż więcej
Źródło :
The American journal of medicine [Am J Med] 2021 Mar; Vol. 134 (3), pp. 412. Date of Electronic Publication: 2021 Jan 05.
Typ publikacji :
Published Erratum
Tytuł :
Prognostic role of left ventricular apical aneurysm in hypertrophic cardiomyopathy: A systematic review and meta-analysis.
Autorzy :
Papanastasiou CA; Center of Cardiomyopathies and Inherited Cardiac Diseases, 1st Cardiology Department, AHEPA University Hospital, Thessaloniki, Greece.
Zegkos T; Center of Cardiomyopathies and Inherited Cardiac Diseases, 1st Cardiology Department, AHEPA University Hospital, Thessaloniki, Greece. Electronic address: .
Karamitsos TD; Center of Cardiomyopathies and Inherited Cardiac Diseases, 1st Cardiology Department, AHEPA University Hospital, Thessaloniki, Greece.
Rowin EJ; Hypertrophic Cardiomyopathy Center and Research Institute, Division of Cardiology, Tufts Medical Center, Boston, MA, United States of America.
Maron MS; Hypertrophic Cardiomyopathy Center and Research Institute, Division of Cardiology, Tufts Medical Center, Boston, MA, United States of America.
Parcharidou D; Center of Cardiomyopathies and Inherited Cardiac Diseases, 1st Cardiology Department, AHEPA University Hospital, Thessaloniki, Greece.
Kokkinidis DG; Section of Cardiovascular Medicine, Department of Medicine, Yale New Haven Hospital, Yale University School of Medicine, New Haven, CT, United States of America.
Karvounis H; Center of Cardiomyopathies and Inherited Cardiac Diseases, 1st Cardiology Department, AHEPA University Hospital, Thessaloniki, Greece.
Rimoldi O; CNR IBFM, Segrate, Italy; Ospedale San Raffaele, Milano, Italy.
Maron BJ; Hypertrophic Cardiomyopathy Center and Research Institute, Division of Cardiology, Tufts Medical Center, Boston, MA, United States of America.
Efthimiadis GK; Center of Cardiomyopathies and Inherited Cardiac Diseases, 1st Cardiology Department, AHEPA University Hospital, Thessaloniki, Greece.
Pokaż więcej
Źródło :
International journal of cardiology [Int J Cardiol] 2021 Jun 01; Vol. 332, pp. 127-132. Date of Electronic Publication: 2021 Mar 29.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Improved Quantification of Myocardium Scar in Late Gadolinium Enhancement Images: Deep Learning Based Image Fusion Approach.
Autorzy :
Fahmy AS; Department of Medicine (Cardiovascular Division), Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA.
Rowin EJ; Hypertrophic Cardiomyopathy Center, Division of Cardiology, Tufts Medical Center, Boston, Massachusetts, USA.
Chan RH; Toronto General Hospital, University Health Network, Toronto, Canada.
Manning WJ; Department of Medicine (Cardiovascular Division), Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA.; Radiology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA.
Maron MS; Hypertrophic Cardiomyopathy Center, Division of Cardiology, Tufts Medical Center, Boston, Massachusetts, USA.
Nezafat R; Department of Medicine (Cardiovascular Division), Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA.
Pokaż więcej
Źródło :
Journal of magnetic resonance imaging : JMRI [J Magn Reson Imaging] 2021 Feb 17. Date of Electronic Publication: 2021 Feb 17.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Individualized interactomes for network-based precision medicine in hypertrophic cardiomyopathy with implications for other clinical pathophenotypes.
Autorzy :
Maron BA; Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. .
Wang RS; Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Shevtsov S; Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Drakos SG; Division of Cardiovascular Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA.; Nora Eccles Harrison Cardiovascular Research and Training Institute (CVRTI), University of Utah School of Medicine, Salt Lake City, UT, USA.
Arons E; Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Wever-Pinzon O; Division of Cardiovascular Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA.
Huggins GS; Hypertrophic Cardiomyopathy Center, Cardiology Division, Tufts Medical Center, Boston, MA, USA.
Samokhin AO; Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Oldham WM; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Aguib Y; Department of Cardiac Surgery, Imperial College of London, London, UK.; The Magdi Yacoub Heart Center, Aswan, Egypt.
Yacoub MH; Department of Cardiac Surgery, Imperial College of London, London, UK.; The Magdi Yacoub Heart Center, Aswan, Egypt.
Rowin EJ; Hypertrophic Cardiomyopathy Center, Cardiology Division, Tufts Medical Center, Boston, MA, USA.
Maron BJ; Hypertrophic Cardiomyopathy Center, Cardiology Division, Tufts Medical Center, Boston, MA, USA.
Maron MS; Hypertrophic Cardiomyopathy Center, Cardiology Division, Tufts Medical Center, Boston, MA, USA.
Loscalzo J; Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Pokaż więcej
Źródło :
Nature communications [Nat Commun] 2021 Feb 08; Vol. 12 (1), pp. 873. Date of Electronic Publication: 2021 Feb 08.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Gene Regulatory Networks*
Precision Medicine*
Cardiomyopathy, Hypertrophic/*pathology
Case-Control Studies ; Cohort Studies ; Endophenotypes ; Fibrosis ; Heart Failure/genetics ; Humans ; Phenotype ; Protein Interaction Maps/genetics ; Signal Transduction ; Transcriptome/genetics
Czasopismo naukowe
Tytuł :
Return to Play for Athletes After Coronavirus Disease 2019 Infection-Making High-Stakes Recommendations as Data Evolve.
Autorzy :
Udelson JE; The CardioVascular Center, Division of Cardiology, Tufts Medical Center, Boston, Massachusetts.
Curtis MA; Exercise and Sports Injury Laboratory, Department of Kinesiology, University of Virginia, Charlottesville.; Men's Basketball Program, Department of Athletics, University of Virginia, Charlottesville.
Rowin EJ; The CardioVascular Center, Division of Cardiology, Tufts Medical Center, Boston, Massachusetts.
Pokaż więcej
Źródło :
JAMA cardiology [JAMA Cardiol] 2021 Feb 01; Vol. 6 (2), pp. 136-138.
Typ publikacji :
Journal Article; Comment
MeSH Terms :
COVID-19*
Return to Sport*
Athletes ; Humans ; SARS-CoV-2
Czasopismo naukowe
Tytuł :
Evolution of risk stratification and sudden death prevention in hypertrophic cardiomyopathy: Twenty years with the implantable cardioverter-defibrillator.
Autorzy :
Maron BJ; HCM Institute, Tufts Medical Center, Boston, Massachusetts. Electronic address: .
Rowin EJ; HCM Institute, Tufts Medical Center, Boston, Massachusetts.
Maron MS; HCM Institute, Tufts Medical Center, Boston, Massachusetts.
Pokaż więcej
Źródło :
Heart rhythm [Heart Rhythm] 2021 Jan 26. Date of Electronic Publication: 2021 Jan 26.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Back to the future: Predicting sudden death in hypertrophic cardiomyopathy relying on individual risk markers and physician judgment without mathematical scoring.
Autorzy :
Maron MS; HCM Center and Research Institute, Tufts Medical Center, Boston, Massachusetts. Electronic address: .
Brush J; Sentara Healthcare and Eastern Virginia Medical School, Norfolk, Virginia.
Rowin EJ; HCM Center and Research Institute, Tufts Medical Center, Boston, Massachusetts.
Maron BJ; HCM Center and Research Institute, Tufts Medical Center, Boston, Massachusetts.
Pokaż więcej
Źródło :
Heart rhythm [Heart Rhythm] 2021 Jan; Vol. 18 (1), pp. 148-150. Date of Electronic Publication: 2020 Jul 25.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Editorial commentary: Hold your horses (and mice, rats, and cats): How relevant really are animal models of hypertrophic cardiomyopathy?
Autorzy :
Maron MS; Hypertrophic Cardiomyopathy Center and Research Institute, Tufts Medical Center, Boston, MA 02111, USA. Electronic address: .
Rowin EJ; Hypertrophic Cardiomyopathy Center and Research Institute, Tufts Medical Center, Boston, MA 02111, USA.
Maron BJ; Hypertrophic Cardiomyopathy Center and Research Institute, Tufts Medical Center, Boston, MA 02111, USA.
Pokaż więcej
Źródło :
Trends in cardiovascular medicine [Trends Cardiovasc Med] 2021 Jan; Vol. 31 (1), pp. 32-33. Date of Electronic Publication: 2019 Dec 18.
Typ publikacji :
Editorial; Comment
MeSH Terms :
Cardiomyopathy, Hypertrophic*/diagnosis
Cardiomyopathy, Hypertrophic*/genetics
Cardiomyopathy, Hypertrophic*/therapy
Animals ; Biological Variation, Population ; Death, Sudden, Cardiac ; Humans ; Mice ; Models, Animal ; Rats
Opinia redakcyjna
Tytuł :
Hypertrophic cardiomyopathy with left ventricular apical aneurysm: the newest high-risk phenotype.
Autorzy :
Maron MS; Division of Cardiology, Hypertrophic Cardiomyopathy Center and Research Institute, Tufts Medical Center, 800 Washington Street, #70, Boston, MA02111, USA.
Rowin EJ; Division of Cardiology, Hypertrophic Cardiomyopathy Center and Research Institute, Tufts Medical Center, 800 Washington Street, #70, Boston, MA02111, USA.
Maron BJ; Division of Cardiology, Hypertrophic Cardiomyopathy Center and Research Institute, Tufts Medical Center, 800 Washington Street, #70, Boston, MA02111, USA.
Pokaż więcej
Źródło :
European heart journal cardiovascular Imaging [Eur Heart J Cardiovasc Imaging] 2020 Dec 01; Vol. 21 (12), pp. 1351-1352.
Typ publikacji :
Editorial; Comment
MeSH Terms :
Cardiomyopathy, Hypertrophic*/complications
Cardiomyopathy, Hypertrophic*/diagnostic imaging
Heart Aneurysm*/diagnostic imaging
Humans ; Magnetic Resonance Spectroscopy ; Phenotype ; Prevalence ; Prognosis
Opinia redakcyjna
Tytuł :
Reply: The LVAD in the Management of Advanced Heart Failure Due to Hypertrophic Cardiomyopathy.
Autorzy :
Rowin EJ
Maron BJ
Maron MS
Pokaż więcej
Źródło :
Journal of the American College of Cardiology [J Am Coll Cardiol] 2020 Oct 20; Vol. 76 (16), pp. 1913. Date of Electronic Publication: 2020 Aug 15.
Typ publikacji :
Letter; Comment
MeSH Terms :
Cardiomyopathy, Hypertrophic*/complications
Cardiomyopathy, Hypertrophic*/therapy
Heart Failure*/etiology
Heart Failure*/therapy
Ventricular Dysfunction, Left*
Humans
Opinia redakcyjna
Tytuł :
Long-Term Outcome in High-Risk Patients With Hypertrophic Cardiomyopathy After Primary Prevention Defibrillator Implants.
Autorzy :
Rowin EJ; Hypertrophic Cardiomyopathy Institute (E.J.R., M.S.M., B.J.M.), Tufts Medical Center, Boston, MA.
Burrows A; Cardiac Arrhythmia Center (A.B., C.M.), Tufts Medical Center, Boston, MA.
Madias C; Cardiac Arrhythmia Center (A.B., C.M.), Tufts Medical Center, Boston, MA.
Estes NAM 3rd; Heart and Vascular Institute, University of Pittsburgh Medical Center, PA (N.A.M.E.).
Link MS; Division of Cardiology, Department of Medicine, UT Southwestern Medical Center, Dallas TX (M.S.L.).
Maron MS; Hypertrophic Cardiomyopathy Institute (E.J.R., M.S.M., B.J.M.), Tufts Medical Center, Boston, MA.
Maron BJ; Hypertrophic Cardiomyopathy Institute (E.J.R., M.S.M., B.J.M.), Tufts Medical Center, Boston, MA.
Pokaż więcej
Źródło :
Circulation. Arrhythmia and electrophysiology [Circ Arrhythm Electrophysiol] 2020 Oct; Vol. 13 (10), pp. e008123. Date of Electronic Publication: 2020 Sep 08.
Typ publikacji :
Journal Article
MeSH Terms :
Defibrillators, Implantable*
Cardiomyopathy, Hypertrophic/*complications
Death, Sudden, Cardiac/*prevention & control
Electric Countershock/*instrumentation
Primary Prevention/*instrumentation
Tachycardia, Ventricular/*therapy
Ventricular Fibrillation/*therapy
Adolescent ; Adult ; Aged ; Boston ; Cardiomyopathy, Hypertrophic/diagnosis ; Cardiomyopathy, Hypertrophic/physiopathology ; Child ; Death, Sudden, Cardiac/etiology ; Electric Countershock/adverse effects ; Electric Countershock/mortality ; Female ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Risk Assessment ; Risk Factors ; Tachycardia, Ventricular/diagnosis ; Tachycardia, Ventricular/etiology ; Tachycardia, Ventricular/physiopathology ; Time Factors ; Treatment Outcome ; Ventricular Fibrillation/diagnosis ; Ventricular Fibrillation/etiology ; Ventricular Fibrillation/physiopathology ; Young Adult
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies